Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia

References

• SinghBNAmiodarone: Historical development and pharmacologic profileAm Heart J19831067887976351575
   PubMed Web of Science ®Google Scholar
• Van SchepdaelJSolvayHEtude Clinique De L’Amiodarone Dans Les Troubles du Rhythme CardiaquePresse Med19707818494096989
   PubMed Web of Science ®Google Scholar
• SinghBNVaughan WilliamsEMThe effect of amiodarone, a new anti-anginal drug, on cardiac muscleBr J Pharmacol19703946576675485142
   PubMed Web of Science ®Google Scholar
• RosenbaumMBChialePAHalpernMSClinical efficacy of amiodarone as an antiarrhythmic agentAm J Cardiol1976387934944793369
   PubMed Web of Science ®Google Scholar
• ConnollySJEvidence-Based Analysis of Amiodarone Efficacy and SafetyCirculation1999100192025203410556230
   PubMed Web of Science ®Google Scholar
• AndreasenFAgerbackHBjerregaardPGotzscheHPharmacokinetics of amiodarone after intravenous and oral administrationEur J Clin Pharmacol19811942932997286032
   PubMed Web of Science ®Google Scholar
• HoItDWTuckerCTJacksonPRStoreyCGAAmiodarone pharmacokineticsAm Heart J19831068408476613830
   PubMed Web of Science ®Google Scholar
• FreedmanMDSombergJCPharmacology and pharmacokinetics of amiodaroneJ Clin Pharmacol19913110611753010
   PubMed Web of Science ®Google Scholar
• Anastasiou-NanaMLewisGMoulopoulosSPlasma levels of amiodarone after intravenous and oral administrationJ Clin Chem Clin Biochem198119599600
   Google Scholar
• PollakPTClinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestationsAm J Cardiol1999849A37R45R10404848
   PubMed Web of Science ®Google Scholar
• KodamaIKamiyaKToyamaJCellular electropharmacology of amiodaroneCardiovasc Res199735113299302343
   PubMed Web of Science ®Google Scholar
• CharlierRCardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptorsBr J Pharmacol1970396686745485143
   PubMed Web of Science ®Google Scholar
• MoradyFDiCarloLAJrKrolRBBaermanJMde BuitleirMAcute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia inductionJ Am Coll Cardiol198671148573941203
   PubMed Web of Science ®Google Scholar
• SagerPTUppalPFollmerCAntimisiarisMPruittCSinghBNFrequency-dependent electrophysiologic effects of amiodarone in humansCirculation1993883106310718353868
   PubMed Web of Science ®Google Scholar
• KudenchukPJCobbLACopassMKAmiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillationN Engl J Med19993411287187810486418
   PubMed Web of Science ®Google Scholar
• DorianPCassDShwartzBAmiodarone as compared with lidocaine for shock resistant ventricular fibrillationN Engl J Med20023461288489011907287
   PubMed Web of Science ®Google Scholar
• MarillKAdeSouzaISNishijimaDKAmiodarone is poorly effective for the acute termination of ventricular tachycardiaAnn Emerg Med200647321722416492484
   PubMed Web of Science ®Google Scholar
• TomlinsonDRCherianPBettsTRBashirYIntravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?Emerg Med J2008251151818156531
   PubMed Web of Science ®Google Scholar
• SchutzenbergerWLeischFKerschnerKHarringerWHerbingerWClinical efficacy of intravenous amiodarone in the short-term treatment of recurrent sustained ventricular tachycardia and ventricular fibrillationBr Heart J19896253673712590589
   PubMedGoogle Scholar
• GorgelsAPvan den DoolAHofsAMulleneersRSmeetsJLVosMAWellensHJComparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardiaAm J Cardiol199678143468712116
   PubMed Web of Science ®Google Scholar
• ScheinmanMMLevineJHCannomDSDose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators GroupCirculation19959211326432727586313
   PubMed Web of Science ®Google Scholar
• LevineJHMassumiAScheinmanMMIntravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial GroupJ Am Coll Cardiol199627167758522712
   PubMed Web of Science ®Google Scholar
• KoweyPRLevineJHHerreJMRandomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators GroupCirculation19959211325532637586312
   PubMed Web of Science ®Google Scholar
• NägeleHBehrensSCastelAVentricular tachycardia and aggravation of Brugada ECG pattern in a patient with coronary artery disease and combined amiodarone and beta-blocker therapyClin Res Cardiol2008971566018075767
   PubMedGoogle Scholar
• PaulGYusufSSharmaSUnmasking of the Brugada syndrome phenotype during the acute phase of amiodarone infusionCirculation200611411e48949116966591
   PubMed Web of Science ®Google Scholar
• ConnollySJHallstromAPCappatoRMeta-analysis of the implantable cardioverter defibrillator secondary prevention trialEur Heart J200021242071207811102258
   PubMed Web of Science ®Google Scholar
• BokhariFNewmanDGreeneMLong-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS)Circulation2004110211211615238454
   PubMed Web of Science ®Google Scholar
• BardyGHLeeKLMarkDBAmiodarone or an implantable cardioverter-defibrillator for congestive heart failureN Engl J Med2005352322523715659722
   PubMed Web of Science ®Google Scholar
• LeeKLHafleyGFisherJDEffect of implantable defibrillators on arrhythmic events and mortality in the Multicenter Unsustained Tachycardia TrialCirculation2002106223323812105164
   PubMed Web of Science ®Google Scholar
• SimIMcDonaldKMLavoriPWQuantitative overview of randomized trials of amiodarone to prevent sudden cardiac deathCirculation1997969282328299386144
   PubMed Web of Science ®Google Scholar
• BoutitieFBoisselJPConnollySJAmiodarone interaction with beta-blockers: analysis of the merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) databasesCirculation199999172268227510226092
   PubMed Web of Science ®Google Scholar
• ConnollySJDorianPRobertsRSComparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillatorsJAMA2006295216517116403928
   PubMed Web of Science ®Google Scholar
• ReddyVYReynoldsMRNeuzilPProphylactic catheter ablation for the prevention of defibrillator therapyN Engl J Med20073572657266518160685
   PubMed Web of Science ®Google Scholar
• KuckK-HSchaumannAEckardtLCatheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trialLancet2010375314020109864
   PubMed Web of Science ®Google Scholar
• RakitaUSobelSMMostowNAmiodarone pulmonary toxicityAm Heart J198310649069146310979
   PubMed Web of Science ®Google Scholar
• PollakPTYouYDMonitoring of hepatic function during amiodarone therapyAm J Cardiol200391561361612615276
   PubMed Web of Science ®Google Scholar
• HaffajeeCILoveICCanadaATClinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrythmiasCirculation1983676134713556851030
   PubMed Web of Science ®Google Scholar
• VorperianVRHavighurstTCMillerSJanuaryCTAdverse effects of low dose amiodarone: a meta-analysisJ Am Coll Cardiol19973037917989283542
   PubMed Web of Science ®Google Scholar
• WolbretteDLRisk of proarrhythmia with class III antiarrhythmic agents: sex-based differences and other issuesAm J Cardiol2003916A39D44D
   PubMed Web of Science ®Google Scholar
• MattioniTAZheutlinTASarmientoJJAmiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacyAnn Intern Med198911175745802774388
   PubMed Web of Science ®Google Scholar
• NademaneeKKannanRHendricksonJAmiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implicationsJ Am Coll Cardiol1984411111166736437
   PubMed Web of Science ®Google Scholar
• Borders-HemphillVConcurrent use of statins and amiodaroneConsult Pharm200924537237919555146
   PubMedGoogle Scholar
• CushingDJKoweyPRCooperWDPM101: A cyclodextrin-based intravenous formulation of amiodarone devoid of adverse hemodynamic effectsEur J Pharmacol20096071–316717219232340
   PubMed Web of Science ®Google Scholar
• KoweyPRMarinchakRARialsSJIntravenous AmiodaroneJ Am Coll Cardiol1997296119011989137212
   PubMed Web of Science ®Google Scholar
• AntonelliDBarzilayJAcute thrombophlebitis following IV amiodarone administrationChest1983841120b120
   Google Scholar
• TagliamonteECiceGDucceschiVAcute hepatitis following amiodarone administrationMinerva Cardioangiol19974594514569446068
   PubMedGoogle Scholar
• HohnloserSHCrijnsHJvan EickelsMEffect of dronedarone on cardiovascular events in atrial fibrillationN Engl J Med2009360766867819213680
   PubMed Web of Science ®Google Scholar
• KoberLTorp-PedersenCMcMurrayJJVIncreased mortality after dronedarone therapy for severe heart failureN Engl J Med2008358252678268718565860
   PubMed Web of Science ®Google Scholar
• KesslerDPalepuNTustianAA novel amiodarone microemulsion injectable formulation. AAPSPharm Sci.20024W4122 (Abstract)
   Google Scholar
• SombergJCBailinSJHaffajeeCIIntravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardiaAm J Cardiol200290885385912372573
   PubMed Web of Science ®Google Scholar
• KippJEDotyMJRebbeckCLEilertJY, inventors; Baxter International, assignee. Amiodarone-containing parenteral administration. United States patent US 6479541. 2002 November 12.
   Google Scholar
• ElhasiSAstanehRLavasanifarASolubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micellesEur J Pharm Biopharm20076540641317291732
   PubMed Web of Science ®Google Scholar
• CushingDJAdamsMPCooperWDBioequivalence of 2 intravenous amiodarone formulations in healthy participantsJ Clin Pharmacol200949440741519246726
   PubMed Web of Science ®Google Scholar
• StellaVJHeQCyclodextrinsToxicol Pathol2008361304218337219
   PubMed Web of Science ®Google Scholar
• Prism Pharmaceuticals NDA for Captisol-enabled Amiodarone NDA; 2008 January.
   Google Scholar